Ursodeoxycholic Acid Market Size – Trends Analysis Report, 2032

Ursodeoxycholic Acid Market – By Type (Synthetic, Biological), Application (Gall Stones, Primary Biliary Cholangitis), Mode (In-house, Contract Manufacturing), Use (Human, Veterinary), Global Forecast, 2023 – 2032 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition &amp; scope

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global ursodeoxycholic acid industry 3600 synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Type trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; Mode trends

2.1.6&nbsp;&nbsp;&nbsp; Use trends

Chapter 3&nbsp;&nbsp;&nbsp;Ursodeoxycholic Acid Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem

3.2&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.3&nbsp;&nbsp;&nbsp; Regulatory landscape

3.3.1&nbsp;&nbsp;&nbsp; U.S.

3.3.2&nbsp;&nbsp;&nbsp; Europe

3.4&nbsp;&nbsp;&nbsp; Pricing analysis, by region

3.4.1&nbsp;&nbsp;&nbsp; Selling price in USD per kg

3.5&nbsp;&nbsp;&nbsp; Innovation &amp; sustainability

3.6&nbsp;&nbsp;&nbsp; Industry impact forces

3.6.1&nbsp;&nbsp;&nbsp; Growth drivers

3.6.1.1&nbsp;&nbsp;&nbsp;Rising prevalence of liver diseases and gallstones

3.6.1.2&nbsp;&nbsp;&nbsp;Growing pharmaceutical industry

3.6.1.3&nbsp;&nbsp;&nbsp;Increasing research and development related to ursodeoxycholic acid

3.6.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.6.2.1&nbsp;&nbsp;&nbsp;Side effects of Ursodeoxycholic acid

3.7&nbsp;&nbsp;&nbsp; Growth potential analysis

3.7.1&nbsp;&nbsp;&nbsp; By type

3.7.2&nbsp;&nbsp;&nbsp; By application

3.7.3&nbsp;&nbsp;&nbsp; By mode

3.7.4&nbsp;&nbsp;&nbsp; By use

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; ICE s.p.a.

4.1.2&nbsp;&nbsp;&nbsp; Merck KGaA

4.1.3&nbsp;&nbsp;&nbsp; Daewoong Bio

4.2&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.3&nbsp;&nbsp;&nbsp; Strategic outlook matrix

4.4&nbsp;&nbsp;&nbsp; Company share analysis, 2022

4.4.1&nbsp;&nbsp;&nbsp; Global

4.4.2&nbsp;&nbsp;&nbsp; North America

4.4.3&nbsp;&nbsp;&nbsp; Europe

4.4.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.5&nbsp;&nbsp;&nbsp; Production capacity

4.6&nbsp;&nbsp;&nbsp; List of top 20 end consumers with contact details/email id

Chapter 5&nbsp;&nbsp;&nbsp;Ursodeoxycholic Acid Market, By Service Type, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; Synthetic ursodeoxycholic acid

5.3&nbsp;&nbsp;&nbsp; Biological ursodeoxycholic acid

Chapter 6&nbsp;&nbsp;&nbsp;Ursodeoxycholic Acid Market, By Application, 2018 &ndash; 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Primary biliary cholangitis

6.3&nbsp;&nbsp;&nbsp; Gallstones

6.4&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Ursodeoxycholic Acid Market, By Mode, 2018 &ndash; 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by mode

7.2&nbsp;&nbsp;&nbsp; In-house manufacturing

7.3&nbsp;&nbsp;&nbsp; Contract manufacturing

Chapter 8&nbsp;&nbsp;&nbsp;Ursodeoxycholic Acid Market, By Use, 2018 &ndash; 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by use

8.2&nbsp;&nbsp;&nbsp; Human

8.3&nbsp;&nbsp;&nbsp; Veterinary

Chapter 9&nbsp;&nbsp;&nbsp;Ursodeoxycholic Acid Market, By Region, 2018 &ndash; 2032 (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; France

9.3.2&nbsp;&nbsp;&nbsp; Italy

9.3.3&nbsp;&nbsp;&nbsp; Germany

9.3.4&nbsp;&nbsp;&nbsp; UK

9.3.5&nbsp;&nbsp;&nbsp; Russia

9.3.6&nbsp;&nbsp;&nbsp; Spain

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; South Korea

9.4.5&nbsp;&nbsp;&nbsp; Australia

9.4.6&nbsp;&nbsp;&nbsp; Malaysia

9.4.7&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; MEA

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Merck KGaA

10.2&nbsp;&nbsp;&nbsp; Changde Yungang Biotechnology Co. Ltd.

10.3&nbsp;&nbsp;&nbsp; Daewoong Bio

10.4&nbsp;&nbsp;&nbsp; Osmopharm SA

10.5&nbsp;&nbsp;&nbsp; ICE s.p.a

10.6&nbsp;&nbsp;&nbsp; Dipharma Francis S.r.l.

10.7&nbsp;&nbsp;&nbsp; Tianjin NWS Biotechnology and Medicine Co. Ltd

10.8&nbsp;&nbsp;&nbsp; Zhongshan Belling Biotechnology Co. Ltd.

10.9&nbsp;&nbsp;&nbsp; Axplora

10.10&nbsp;&nbsp;&nbsp; Anant Pharmaceuticals Pvt Ltd

10.11&nbsp;&nbsp;&nbsp; IOL Chemicals and Pharmaceuticals

10.12&nbsp;&nbsp;&nbsp; Glenmark Pharmaceuticals

10.13&nbsp;&nbsp;&nbsp; Cerata Pharmaceuticals

10.14&nbsp;&nbsp;&nbsp; Kimia Biosciences Ltd 
&nbsp;

Ursodeoxycholic Acid Market

Get a free sample of this report